Riluzole suppresses experimental autoimmune encephalomyelitis: implications for the treatment of multiple sclerosis.
about
Glutamate receptors in neuroinflammatory demyelinating diseaseNeuroendocrine immunoregulation in multiple sclerosisEmerging therapies in multiple sclerosis.A randomized controlled phase II trial of riluzole in early multiple sclerosis.Axonal damage accumulates in the progressive phase of multiple sclerosis: three year follow up study.Concurrent multiple sclerosis and amyotrophic lateral sclerosis: where inflammation and neurodegeneration meet?Reversal of axonal loss and disability in a mouse model of progressive multiple sclerosis.Phosphorylation and compactness of neurofilaments in multiple sclerosis: indicators of axonal pathology.Protecting axons in multiple sclerosis.Advancement of therapies for neuroprotection in multiple sclerosis.The link between inflammation, synaptic transmission and neurodegeneration in multiple sclerosis.Translational research in neurology and neuroscience 2010: multiple sclerosisCannabinoids, multiple sclerosis and neuroprotection.Neuroprotection in multiple sclerosis: a therapeutic approach.Dysfunction of neuronal calcium signalling in neuroinflammation and neurodegeneration.Vitamin D as a potential therapy in amyotrophic lateral sclerosis.Synaptopathy connects inflammation and neurodegeneration in multiple sclerosis.Prevention of axonal injury using calpain inhibitor in chronic progressive experimental autoimmune encephalomyelitis.A double-blind, placebo controlled, randomized trial of riluzole as an adjunct to risperidone for treatment of negative symptoms in patients with chronic schizophrenia.Glutamate-stimulated peroxynitrite production in a brain-derived endothelial cell line is dependent on N-methyl-D-aspartate (NMDA) receptor activation.Recent Advances on the Possible Neuroprotective Activities of Epstein-Barr Virus Oncogene BARF1 Protein in Chronic Inflammatory Disorders of Central Nervous System.Modulation of neurological deficits and expression of glutamate receptors during experimental autoimmune encephalomyelitis after treatment with selected antagonists of glutamate receptors.Implications of white matter damage in amyotrophic lateral sclerosis (Review).Riluzole: validation of stability-indicating HPLC, D1 and DD1 spectrophotometric assays.Riluzole as an adjunctive therapy to risperidone for the treatment of irritability in children with autistic disorder: a double-blind, placebo-controlled, randomized trial.Glutamate receptor expression in multiple sclerosis lesions.
P2860
Q21284455-EDC90B35-CA5D-459E-ABD0-D037BEC53B9EQ26864449-3065A24A-5E20-44B1-864D-0B05F67FC308Q31015100-EAD0AA80-D20F-4A43-B046-9A865F4CB556Q34286809-98248B59-E0C0-422A-8B77-A511118DC9F3Q35485799-ED592027-0470-4395-910C-304BCF1E3B20Q35842339-F40BA2C9-8928-4B85-8576-F6AC1D74A814Q36494558-D375B5AF-EAD6-489E-A36E-EEF5D846EF5FQ36973566-4DD35174-574F-4940-8E78-E1ADF40694ACQ37218580-A081F8D8-D3DC-41B6-AB84-2DDF039D5EACQ37256701-C7126174-0733-4358-B4D1-F8ECC93C83D4Q37635764-F4C79E93-1BAC-46B0-8ABC-56569FA5D045Q37772026-91A0CCF9-940C-4CB2-9763-DA1025B81F93Q37960199-2701E961-A6CD-4C54-BAD1-8BBED3C4448FQ38129748-41515234-9B92-4E66-96D4-ACDEE7A9D469Q38170257-1FBD5C7D-2476-4B68-8466-0E107452AE27Q38178758-8A7F0ADF-7C0A-4B60-857C-8979694859EDQ38639337-5810EC1A-55B3-49ED-B893-5260EB005E50Q38713740-5925BD99-15DC-45FF-8857-2FF1149EA0B0Q39220948-90B28920-671C-4835-A08C-2D99A7DECD6AQ40205958-1287BFDE-28F5-42F3-9CF0-CCDC0F0F5DA6Q41136819-85F4AABC-7F30-47FF-A4BE-65DE9C29F4EBQ42071980-D4643F0E-5107-4607-AFED-0573665476AFQ42658376-DA95E888-3F20-4AD2-878D-154C09C83743Q43946376-2E0706FE-4D7B-4C73-B7CA-C95DDFFCEBF5Q44127880-123D100E-ADB9-4DE9-96E4-A12C0429CB38Q46959335-B90024D9-BEB8-484C-A064-0F9519C014B8
P2860
Riluzole suppresses experimental autoimmune encephalomyelitis: implications for the treatment of multiple sclerosis.
description
2003 nî lūn-bûn
@nan
2003年の論文
@ja
2003年学术文章
@wuu
2003年学术文章
@zh
2003年学术文章
@zh-cn
2003年学术文章
@zh-hans
2003年学术文章
@zh-my
2003年学术文章
@zh-sg
2003年學術文章
@yue
2003年學術文章
@zh-hant
name
Riluzole suppresses experiment ...... eatment of multiple sclerosis.
@en
Riluzole suppresses experiment ...... eatment of multiple sclerosis.
@nl
type
label
Riluzole suppresses experiment ...... eatment of multiple sclerosis.
@en
Riluzole suppresses experiment ...... eatment of multiple sclerosis.
@nl
prefLabel
Riluzole suppresses experiment ...... eatment of multiple sclerosis.
@en
Riluzole suppresses experiment ...... eatment of multiple sclerosis.
@nl
P2093
P1433
P1476
Riluzole suppresses experiment ...... eatment of multiple sclerosis.
@en
P2093
Daniel Offen
Eldad Melamed
Hana Panet
Yossi Gilgun-Sherki
P304
P356
10.1016/S0006-8993(03)03343-2
P407
P577
2003-11-01T00:00:00Z